Please login to the form below

Not currently logged in
Email:
Password:

Amgen appoints CEO Robert Bradway to chair of board

Replaces Kevin Sharer who retires

Robert Bradway, AmgenAmgen's CEO Robert Bradway (pictured) has been named the company's chair of the board of directors, replacing Kevin Sharer who will retire at the end of the year.

The move follows Bradway's replacement of Sharer as Amgen's CEO in May, 2012, completing a succession process that was originally announced a year ago.

Bradway joined the company in 2006 as VP, operations strategy, before being appointed to executive VP and chief financial officer and then chief operating officer. Prior to joining the company, he was managing director of Morgan Stanley.

Sharer's departure ends his 20-year involvement with Amgen, including 12 years as CEO from 2000. During his time as head of the company, its annual revenue grew from $3.6bn to $16bn.

Bradway's appointment wasn't the only change at the top for Amgen, with director Vance Coffman appointed lead independent director.

"On behalf of the board and all of Amgen, we look forward to Vance Coffman's continued contributions as the new lead independent director," said Bradway, "and we thank Kevin Sharer for his 20 years of dedicated service and his contributions to the company and the patients we serve."

In addition, Amgen also announced the appointment of a new board member, with former CEO at toy company Mattel, Robert Eckert, to serve on the audit and corporate responsibility and compliance committees of the board.

"We are pleased to welcome Bob Eckert to the Amgen Board. Bob has significant experience and a superb track record of leading global companies during a long and successful career," said Bradway.

17th December 2012

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics